Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Advancing Cell Therapy Manufacturing with Dissolvable Microcarriers
Published on: July 7, 2023
Methods and practices to diversify cell-based products
1London Business School, UK & NxR Biotechnologies GmbH, Basel, Switzerland.
Abstract:
Medicinal signaling cell (MSC)-based products represent emerging treatments in various therapeutic areas including cardiometabolic, inflammation, autoimmunity, orthopedics, wound healing and oncology. Exploring innovation beyond minimally manipulated plastic-adherent ex vivo expanded allogeneic MSCs enables product delineation. Product delineation is on the critical path to maximize clinical benefits and market access. An innovation framework is presented here along various innovation dimensions comprising composition-of-matter by means of positive cell surface markers, formulation varying for example the cell dose or the preservation mode and medium, manufacturing to adapt the secretome of MSCs to the condition of interest, the mode of delivery and corresponding delivery devices, as well as molecular engineering and biomarkers. The rationale of the innovation space thus described applies generally to all cell-based therapies.
Related Concept Videos
Overview Of Cell Separation And Isolation
Cell Culture
Cell Lines
iPS Cell Differentiation
Methods of Nuclear Reprogramming
Stem Cell Culture

